Psychiatry Presentations
The impressive selection of Psychiatry Presentations includes research in psychotherapy, bioethics, antidepressant medications and, the connection of mind and body.
Submissions from 2015
Brain maturation, poverty and social exclusion: Shifting paradigms of psychopathology, Amresh Srivastava
Submissions from 2011
Beyond Early Intervention, Amresh Srivastava
Pregnant Women as Research Participants: Why Is Additional Protection Required?, Kyoko Wada
Submissions from 2010
Current Understanding and Pharmacological Management of Suicide Behavior in Clinical Setting, Amresh Shrivastava
Predictors and Characteristics of Response and Nonresponse: A Ten Year Follow-Up of First Episode Schizophrenia in Mumbai, Amresh Shrivastava, Nilesh Shah, Megan Johnston, Larry Stitt, Meghana Thakar, and Gurusamy Chinnasamy
Should 'Risk Syndrome of Psychosis' Be Included in DSM V as a Diagnosis? A Road towards Preventive Psychiatry, Amresh Srivastava
Enhancing Risk Assessment across Mental Health Services, Amresh Srivastava, Megan Johnston, and Charles Nelson
Psychoendocrinology (Thyroid Hormone) and Early Psychosis: Preliminary Findings, Amresh Srivastava, Megan Johnston, Lenore Purde, and Robbie Campbell
Serum Lipids and Suicidality in Early Psychosis: Is There a Connection? A Preliminary Study, Amresh Srivastava, Megan Johnston, Lenore Purde, and Robbie Campbell
Antipsychotics and Outcome in Schizophrenia, Amresh Srivastava and Anukant Mital
Do Atypical Antipsychotics Differ in Determining Long-term Outcome of First Episode Schizophrenia? A Naturalistic Outcome Study in India, Amresh Srivastava, Nilesh Shah, Megan Johnston, Larry Stitt, Meghana Thakar, Gurusamy Chinnasamy, and Anukant Mital
Never the Twain Shall Meet? Interspecialty Bioethics Education and Practice in Relation to Informed Consent for Surgery-related Anesthesia, Kyoko Wada and Abraham Rudnick
Submissions from 2009
Clinical Interview for Psychiatric Assessment, Amresh Srivastava
Early Psychosis: A Novel Gateway for Suicide Prevention, Amresh Srivastava
Identifying Schizophrenia: Paradigm Shift ‘The UHR Research’, Amresh Srivastava
Selecting Antidepressant Drugs for Management of Depression in Primary Care (Part 1), Amresh Srivastava
Selecting Antidepressant Drugs for Management of Depression in Primary Care (Part 2), Amresh Srivastava
Should Schizoaffective Disorder Be Dropped from DSM V, Amresh Srivastava
Switching and Selecting Atypical Antipsychotic Drugs: Paliperidone, Amresh Srivastava
Switching and Selecting Atypical Antipsychotic Drugs: Quetiapine, Amresh Srivastava
Treatment Resistant Depression, Amresh Srivastava
Coping up Challenges of Risk Assessment: Towards a New Scale: SIS-MAP, Amresh Srivastava and Charles Nelson
First Episode Is the Best Episode: Lessons and Limitations in Duration of Untreated Psychosis (DUP) and Outcome in Schizophrenia, Amresh Srivastava, Larry Stitt, Meghana Thakar, Gurusamy Chinnasamy, and Nilesh Shah
Baseline Serum Prolactinin Drug Naïve First Episode Schizophrenia Predicts a Positive Clinical and Social Outcome at Five Years, Post Discharge Follow-up, Amresh Srivastava, Manoj Tamhane, Meghana Thakar, Yves Bureau, and Nilesh Shah
Submissions from 2008
Cannabis & Psychosis: The Interface Emerging Frontiers for Research, Amresh Shrivastava